BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cunha AD, Michelin MA, Murta EF. Pattern response of dendritic cells in the tumor microenvironment and breast cancer. World J Clin Oncol 2014; 5(3): 495-502 [PMID: 25114862 DOI: 10.5306/wjco.v5.i3.495]
URL: https://www.wjgnet.com/2218-4333/full/v5/i3/495.htm
Number Citing Articles
1
Jarupa Soongsathitanon, Pranisa Jamjuntra, Nuttavut Sumransub, Supaporn Yangngam, Marjorie De la Fuente, Glauben Landskron, Peti Thuwajit, Marcela A. Hermoso, Chanitra Thuwajit, Alexandre Keller. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast CancerJournal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/8840066
2
Manzoor A. Mir, Shazia Sofi, Hina Qayoom. Combinational Therapy in Triple Negative Breast Cancer2022; : 121 doi: 10.1016/B978-0-323-96136-3.00014-5
3
Adam Hermawan, Herwandhani Putri, Nurul Fatimah, Heri Himawan Prasetio. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cellsHeliyon 2024; 10(2): e24356 doi: 10.1016/j.heliyon.2024.e24356
4
Mihaela Antohe, Roxana Nedelcu, Luciana Nichita, Cristiana Popp, Mirela Cioplea, Alice Brinzea, Anastasia Hodorogea, Andreea Calinescu, Mihaela Balaban, Daniela Ion, Carmen Diaconu, Coralia Bleotu, Daniel Pirici, Sabina Zurac, Gabriela Turcu. Tumor infiltrating lymphocytes: The regulator of melanoma evolution (Review)Oncology Letters 2019;  doi: 10.3892/ol.2019.9940
5
S. Muenst, H. Läubli, S. D. Soysal, A. Zippelius, A. Tzankov, S. Hoeller. The immune system and cancer evasion strategies: therapeutic conceptsJournal of Internal Medicine 2016; 279(6): 541 doi: 10.1111/joim.12470
6
Benjamin Gordon, Vijayakrishna K. Gadi. The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer VaccinesVaccines 2020; 8(3): 529 doi: 10.3390/vaccines8030529
7
Cristina Ferreira Almeida, Georgina Correia-da-Silva, Natércia Teixeira, Cristina Amaral. Influence of tumor microenvironment on the different breast cancer subtypes and applied therapiesBiochemical Pharmacology 2024; 223: 116178 doi: 10.1016/j.bcp.2024.116178
8
Ana I. Faustino-Rocha, Rita Ferreira, Adelina Gama, Paula A. Oliveira, Mário Ginja. Antihistamines as promising drugs in cancer therapyLife Sciences 2017; 172: 27 doi: 10.1016/j.lfs.2016.12.008
9
Huan-Rong Lan, Wen-Lin Du, Yuyao Liu, Chun-Sen Mao, Ke-Tao Jin, Xue Yang. Role of immune regulatory cells in breast cancer: Foe or friend?International Immunopharmacology 2021; 96: 107627 doi: 10.1016/j.intimp.2021.107627
10
Kai Shi, Jiatian Tang, Lingyan Yuan, Shengwen Zhou, Wei Ran, Zhiming Wang. Role of gene signature regulation in tumor immune microenvironment on the mechanism of uveal melanoma metastasisCancer Biomarkers 2023; 36(2): 161 doi: 10.3233/CBM-210427
11
Qiujun Guo, Jinyin Lin, Rui Liu, Yebo Gao, Shulin He, Xinyao Xu, Baojin Hua, Conghuang Li, Wei Hou, Honggang Zheng, Yanju Bao. Review on the Applications and Molecular Mechanisms ofXihuangPill in Tumor TreatmentEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/854307
12
Sijia Han, Xueying Jin, Tianyu Hu, Feng Chi. ARHGAP25 suppresses the development of breast cancer by an ARHGAP25/Wnt/ASCL2 feedback loopCarcinogenesis 2023; 44(5): 369 doi: 10.1093/carcin/bgad042
13
Chiara Massa, Barbara Seliger. The tumor microenvironment: Thousand obstacles for effector T cellsCellular Immunology 2019; 343: 103730 doi: 10.1016/j.cellimm.2017.12.004
14
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler, Walter Berger. Metal Drugs and the Anticancer Immune ResponseChemical Reviews 2019; 119(2): 1519 doi: 10.1021/acs.chemrev.8b00396
15
Xiao Chen, Chenxu Meng, Xinyu Wang, Zanhui Wu, Xinyue Sun, Chenyu Sun, Lu Zheng, Wanwan Li, WenJun Jia, Tong Tang. Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signalingJournal of Cancer Research and Clinical Oncology 2024; 150(2) doi: 10.1007/s00432-023-05600-6
16
Gangga Anuraga, Wei-Jan Wang, Nam Nhut Phan, Nu Thuy An Ton, Hoang Dang Khoa Ta, Fidelia Berenice Prayugo, Do Thi Minh Xuan, Su-Chi Ku, Yung-Fu Wu, Vivin Andriani, Muhammad Athoillah, Kuen-Haur Lee, Chih-Yang Wang. Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast CancerJournal of Personalized Medicine 2021; 11(11): 1089 doi: 10.3390/jpm11111089
17
Dharmendra Kumar, Pramod K. Sharma, Rishabha Malviya. Modification of Tumor Microenvironment Utilizing Nanotechnology Advancement for Better Therapeutic EffectNanoscience & Nanotechnology-Asia 2021; 11(1): 14 doi: 10.2174/2210681210666200108125840
18
Marina Vitorino, Diogo Alpuim Costa, Rodrigo Vicente, Telma Caleça, Catarina Santos. Local Breast Microbiota: A “New” Player on the BlockCancers 2022; 14(15): 3811 doi: 10.3390/cancers14153811
19
Joanna Szpor, Joanna Streb, Anna Glajcar, Anna Streb-Smoleń, Agnieszka Łazarczyk, Paulina Korta, Karolina Brzuszkiewicz, Robert Jach, Diana Hodorowicz-Zaniewska. Dendritic Cell Subpopulations Are Associated with Morphological Features of Breast Ductal Carcinoma In SituInternational Journal of Molecular Sciences 2023; 24(12): 9918 doi: 10.3390/ijms24129918
20
Jiaojiao Wang, Lijie Song, Sen Yang, Weijie Zhang, Pengwei Lu, Shenglei Li, Huixiang Li, Liuxing Wang. HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma-not otherwise specifiedMolecular Medicine Reports 2017; 16(4): 4634 doi: 10.3892/mmr.2017.7131
21
Zehuan Li, Yiran Qiu, Weiqi Lu, Ying Jiang, Jin Wang. Immunotherapeutic interventions of Triple Negative Breast CancerJournal of Translational Medicine 2018; 16(1) doi: 10.1186/s12967-018-1514-7
22
Xiao Chen, Chenxu Meng, WenJun Jia, Ying Zhang, Wanwan Li, Tong Tang. CCL11 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Breast CancerSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3985263
23
L. N. Bondar, L. A. Tashireva, O. V. Savenkova, E. L. Choynzonov, V. M. Perelmuter. THE ROLE OF INTRATUMORAL DENDRITIC CELLS IN THE PROGRESSION OF SQUAMOUS CELL CARCINOMASSiberian journal of oncology 2019; 18(4): 50 doi: 10.21294/1814-4861-2019-18-4-50-58
24
Karin Zins, Gerwin Heller, Mathias Mayerhofer, Martin Schreiber, Dietmar Abraham. Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypesOncotarget 2018; 9(33): 23126 doi: 10.18632/oncotarget.25226
25
Alessandra da Cunha, Marcia Antoniazi Michelin, Eddie Fernando Cândido Murta. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapyImmunology Letters 2016; 177: 25 doi: 10.1016/j.imlet.2016.07.009
26
Sathana Dushyanthen, Peter Savas, Karen Willard-Gallo, Carsten Denkert, Roberto Salgado, Sherene Loi. Tumour-Infiltrating Lymphocytes (TILs) in Breast Cancer: a Predictive or a Prognostic Marker?Current Breast Cancer Reports 2015; 7(1): 59 doi: 10.1007/s12609-014-0178-4
27
Diana Behrens, Jana Rolff, Jens Hoffmann. New Approaches to Drug DiscoveryHandbook of Experimental Pharmacology 2015; 232: 203 doi: 10.1007/164_2015_29
28
Mikio Kajihara, Kazuki Takakura, Toshifumi Ohkusa, Shigeo Koido. The Impact of Dendritic Cell–Tumor Fusion Cells on Cancer Vaccines - Past Progress and Future StrategiesImmunotherapy 2015; 7(10): 1111 doi: 10.2217/imt.15.73
29
Sharada H. Sharma, Senthilkumar Thulasingam, Sangeetha Nagarajan. Chemopreventive agents targeting tumor microenvironmentLife Sciences 2016; 145: 74 doi: 10.1016/j.lfs.2015.12.016
30
Daniel Sigal, Michelle Przedborski, Darshan Sivaloganathan, Mohammad Kohandel. Mathematical modelling of cancer stem cell-targeted immunotherapyMathematical Biosciences 2019; 318: 108269 doi: 10.1016/j.mbs.2019.108269
31
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapiesSeminars in Cancer Biology 2021; 72: 76 doi: 10.1016/j.semcancer.2019.12.018
32
Savas D. Soysal, Alexandar Tzankov, Simone E. Muenst. Role of the Tumor Microenvironment in Breast CancerPathobiology 2015; 82(3-4): 142 doi: 10.1159/000430499
33
Carlos López, Ramon Bosch, Guifre Orero, Anna Korzynska, Marcial García-Rojo, Gloria Bueno, María del Milagro Fernández-Carrobles, Albert Gibert-Ramos, Lukasz Roszkowiak, Cristina Callau, Laia Fontoura, Maria-Teresa Salvadó, Tomás Álvaro, Joaquín Jaén, Albert Roso-Llorach, Montserrat Llobera, Julia Gil, Montserrat Onyos, Benoît Plancoulaine, Jordi Baucells, Marylène Lejeune. The Immune Response in Nonmetastatic Axillary Lymph Nodes Is Associated with the Presence of Axillary Metastasis and Breast Cancer Patient OutcomeThe American Journal of Pathology 2020; 190(3): 660 doi: 10.1016/j.ajpath.2019.11.002
34
Lindsey Devisscher, Margherita Vieri, Susan E. Logue, Jens Panse, Anja Geerts, Hans van Vlierberghe, Eric Chevet, Adrienne M. Gorman, Afshin Samali, Behzad Kharabi Masouleh. Targeting the angio-proteostasis network: Combining the forces against cancerPharmacology & Therapeutics 2016; 167: 1 doi: 10.1016/j.pharmthera.2016.07.007
35
Yingjie Nie, De Yang, Joost J. Oppenheim. Alarmins and Antitumor ImmunityClinical Therapeutics 2016; 38(5): 1042 doi: 10.1016/j.clinthera.2016.03.021
36
M.V. Mnikhovich, A.V. Romanov, T.M. Nguyen, T.V. Bezuglova, D.A. Pastukhova. Histological and electron microscopic features of the extracellular matrix of invasive breast ductal carcinoma of no special type. Report of 5 cases and literature reviewUltrastructural Pathology 2023; 47(4): 261 doi: 10.1080/01913123.2023.2209162